SCHEMBL92617

SCHEMBL92617

CCOC[C@H]1CCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10273858 1.00
SCHEMBL3330177 0.84
SCHEMBL10273866 0.84
SCHEMBL10273867 0.84
SCHEMBL22018875 0.82 LTA4H (0.42)
Hydrochloric Acid SCHEMBL3442787 0.82 CHRNA3 (0.44)
SCHEMBL12464310 0.82 LTA4H (0.42)
Hydrochloric Acid SCHEMBL3442784 0.82 CHRNA3 (0.44)
Hydrochloric Acid SCHEMBL18700859 0.82 CHRNA3 (0.44)
SCHEMBL92618 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130065882-A1 VLA-4 inhibitory drug MACHINAGA NOBUO (JP) 2013-03-14 US disclosed
US-20120157437-A1 VLA-4 INHIBITORY DRUG DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-06-21 US disclosed
US-8129366-B2 VLA-4 inhibitory drug DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-03-06 US disclosed
US-20090233901-A1 VLA-4 INHIBITORY DRUG DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-09-17 US disclosed